Johnson’s recommendation to suspend vaccination in the United States
The United States has recommended that Johnson & Johnson’s vaccine be suspended to prevent coronavirus (Covid-19). The country’s two central agencies made the recommendation in a joint statement on Tuesday. This has been recommended considering the potential risk of blood clots as a result of the application of this vaccine.
Earlier, the University of Oxford and AstraZeneca had reported blood clots in the corona vaccine. However, no final decision has been reached yet. Meanwhile, similar news was published about Johnson’s vaccine.
More than 600,000 doses of Johnson’s vaccine have already been administered in the United States, according to Reuters. Six women under the age of 50 who received the vaccine reported blood clots in their bodies. The United States has said in a statement that it would suspend the use of the vaccine. The two agencies are the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). The two organizations say the six women are between 18 and 48 years old. Within 7 to 13 days of vaccination, they begin to show signs of blood clots. They are investigating the matter.
“As a precautionary measure, it is recommended to suspend the use of Johnson & Johnson vaccines until the investigation is completed,” the joint statement said.
The White House said in a statement that the suspension of Johnson’s vaccination would not have a major impact on the overall vaccination program in the United States. The government has set a target of vaccinating 200 million people within 100 days of new US President Joe Biden taking office. For this, 3 million dose of ticker is being applied in the country every day. The US CDC’s advisory committee on immunization practice will discuss this on Wednesday. In addition, the FDA has begun an investigation into blood clots.
According to Qatar-based Al Jazeera, Johnson & Johnson’s recommendation to suspend immunization in the United States is another major blow to the organization. Earlier last month, unintentional vaccine contamination of workers at the Baltimore factory was reported. This forced about one and a half crore doses of vaccine.
Public health experts fear Johnson & Johnson’s allegations of blood clots in the vaccine will further discourage those who are reluctant to take the vaccine from health authorities.
Like Johnson & Johnson, the Oxford-AstraZeneca in the UK is in trouble in the European market. The same technology is used for both ticks. It uses mutated and harmless viruses. The use of the Oxford and AstraZeneca vaccines has resulted in very low blood clots in some countries. Since then, many countries have stopped using the vaccine. In some countries the vaccine is only given to older people.